NCT05749081View on ClinicalTrials.gov

Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

May 13, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Lacidophilin tablets in combination with vonorazan dual therapy

2400mg lacidophilin tablets three times daily,1000mg amoxicillin capsules three times daily and 20mg vonoprazan Fumarate Tablets twice daily for 10 days

DRUG

Placebo in combination with vonorazan dual therapy

2400mg placebo three times daily,1000mg amoxicillin capsules three times daily and 20mg vonoprazan Fumarate Tablets twice daily for 10 days

Trial Locations (1)

Unknown

The first affiliated hospital, Jiangxi Medical College, NanChang University, Nanchang

All Listed Sponsors
lead

The First Affiliated Hospital of Nanchang University

OTHER